Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pesg PNH diagnosis, follow-up and treatment guidelines.
Sahin F, Akay OM, Ayer M, Dal MS, Ertop S, Ilhan O, Karakus V, Ozcan MA, Ozkocaman V, Ozsan H, Salim O, Tobu M, Tombak A, Tuglular TF, Yilmaz M, Unal A, Yenerel MN, Saydam G. Sahin F, et al. Among authors: ayer m. Am J Blood Res. 2016 Aug 5;6(2):19-27. eCollection 2016. Am J Blood Res. 2016. PMID: 27570707 Free PMC article. Review.
Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.
Karadag FK, Yenerel MN, Yılmaz M, Uskudar H, Ozkocaman V, Tuglular TF, Erdem F, Unal A, Ayyildiz O, Ozet G, Comert M, Kaya E, Ayer M, Salim O, Guvenc B, Ozdogu H, Mehtap Ö, Sonmez M, Guler N, Hacioglu S, Aydogdu İ, Bektas O, Toprak SK, Kaynar L, Yagci M, Aksu S, Tombak A, Karakus V, Yavasoglu İ, Onec B, Ozcan MA, Undar L, Ali R, Ilhan O, Saydam G, Sahin F. Karadag FK, et al. Among authors: ayer m. Am J Blood Res. 2021 Jun 15;11(3):279-285. eCollection 2021. Am J Blood Res. 2021. PMID: 34322292 Free PMC article.
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience.
Çekdemir D, Güvenç S, Özdemirkıran F, Eser A, Toptaş T, Özkocaman V, Haydaroğlu Şahin H, Ermiş Turak E, Esen R, Cömert M, Sadri S, Aslaner M, Uncu Ulu B, Karakuş A, Selim Bapur D, Alacacıoğlu İ, Aydın D, Tekinalp A, Namdaroğlu S, Ceran F, Tarkun P, Kiper D, Çetiner M, Yenerel M, Demir AM, Yılmaz G, Terzi H, Atilla E, Malkan ÜY, Acar K, Öztürk E, Tombak A, Sunu C, Salim O, Alayvaz N, Sayan Ö, Ozan Ü, Ayer M, Gökgöz Z, Andıç N, Kızılkılıç E, Noyan F, Özen M, Pepedil Tanrıkulu F, Alanoğlu G, Özkan HA, Aslan V, Çetin G, Akyol Erikçi A, Deveci B, Ersoy Dursun F, Dermenci H, Aytan P, Gündüz M, Karakuş V, Özlü C, Demircioğlu S, Akay Yanar OM, Özatlı D, Ündar L, Tiftik EN, Türköz Sucak AG, Haznedaroğlu İ, Özcan M, Şencan M, Tombuloğlu M, Özet G, Bilgir O, Turgut B, Özcan MA, Payzın KB, Sönmez M, Ayyıldız O, Dal MS, Ertop Ş, Turgut M, Soysal T, Kaya E, Ünal A, Pehlivan M, Atagündüz I, Tuğlular Fıratlı T, Saydam G, Diz Küçükkaya R. Çekdemir D, et al. Among authors: ayer m. Turk J Haematol. 2019 Nov 18;36(4):230-237. doi: 10.4274/tjh.galenos.2019.2018.0307. Epub 2019 Jul 22. Turk J Haematol. 2019. PMID: 31327186 Free PMC article.
Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
Yildirim ND, Ayer M, Küçükkaya RD, Alpay N, Mete O, Yenerel MN, Yavuz AS, Nalçaci M. Yildirim ND, et al. Among authors: ayer m. Jpn J Clin Oncol. 2007 Sep;37(9):704-7. doi: 10.1093/jjco/hym092. Epub 2007 Aug 20. Jpn J Clin Oncol. 2007. PMID: 17709605
Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis.
Sarıman M, Abacı N, Sırma Ekmekçi S, Çakiris A, Perçin Paçal F, Üstek D, Ayer M, Yenerel MN, Beşışık S, Çefle K, Palandüz Ş, Öztürk Ş. Sarıman M, et al. Among authors: ayer m. Balkan Med J. 2019 Jan 1;36(1):23-31. doi: 10.4274/balkanmedj.2018.0356. Epub 2018 Aug 6. Balkan Med J. 2019. PMID: 30079703 Free PMC article.
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.
Eskazan AE, Sadri S, Keskin D, Ayer M, Kantarcioglu B, Demirel N, Aydin D, Aydinli F, Yokus O, Ozunal IE, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Eskazan AE, et al. Among authors: ayer m. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):804-811. doi: 10.1016/j.clml.2017.07.255. Epub 2017 Aug 4. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28847475
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.
Eskazan AE, Ayer M, Kantarcioglu B, Arica D, Demirel N, Aydin D, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Eskazan AE, et al. Among authors: ayer m. Br J Haematol. 2014 Oct;167(1):139-41. doi: 10.1111/bjh.12937. Epub 2014 May 10. Br J Haematol. 2014. PMID: 24815307 Free article. No abstract available.
65 results